Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative

Ellen M. Denzen; Navneet S. Majhail; Stacy Stickney Ferguson; Claudio Anasetti; Arthur Bracey; Linda Burns; Richard Champlin; Jeffrey Chell; Helen Leather; Michael Lill; Richard T. Maziarz; Erin Medoff; Joyce Neumann; Kim Schmit-Pokorny; Edward L. Snyder; Laura Wiggins; Deborah S. Yolin Raley; Elizabeth A. Murphy

doi:10.1016/j.bbmt.2012.10.005

Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative

Ellen M. Denzen
, Navneet S. Majhail
, Stacy Stickney Ferguson
, Claudio Anasetti
, Arthur Bracey
, Linda Burns
, Richard Champlin
, Jeffrey Chell
, Helen Leather
, Michael Lill
, Richard T. Maziarz
, Erin Medoff
, Joyce Neumann
, Kim Schmit-Pokorny
, Edward L. Snyder
, Laura Wiggins
, Deborah S. Yolin Raley
, Elizabeth A. Murphy

Knight Cancer Institute

Research output: Contribution to journal › Article › peer-review

31 Scopus citations

Abstract

The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. " Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.

Original language	English (US)
Pages (from-to)	4-11
Number of pages	8
Journal	Biology of Blood and Marrow Transplantation
Volume	19
Issue number	1
DOIs	https://doi.org/10.1016/j.bbmt.2012.10.005
State	Published - Jan 2013

Funding

Financial disclosure: Funding for this conference was made possible (in part) by grant 1R13HL110705-01 from the National Institutes of Health, Yale School of Medicine, Yale University and the National Marrow Donor Program . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the US Government. The authors have no conflicts of interest to disclose.

Funders	Funder number
Yale University School of Medicine
Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health
National Institute of Health National Heart, Lung, and Blood Institute	R13HL110705

Keywords

Allogeneic transplant
Care delivery model
Healthcare disparities
Reimbursement
Workforce

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1016/j.bbmt.2012.10.005

Cite this

Denzen, E. M., Majhail, N. S., Stickney Ferguson, S., Anasetti, C., Bracey, A., Burns, L., Champlin, R., Chell, J., Leather, H., Lill, M., Maziarz, R. T., Medoff, E., Neumann, J., Schmit-Pokorny, K., Snyder, E. L., Wiggins, L., Yolin Raley, D. S., & Murphy, E. A. (2013). Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative. Biology of Blood and Marrow Transplantation, 19(1), 4-11. https://doi.org/10.1016/j.bbmt.2012.10.005

Denzen, EM, Majhail, NS, Stickney Ferguson, S, Anasetti, C, Bracey, A, Burns, L, Champlin, R, Chell, J, Leather, H, Lill, M, Maziarz, RT, Medoff, E, Neumann, J, Schmit-Pokorny, K, Snyder, EL, Wiggins, L, Yolin Raley, DS & Murphy, EA 2013, 'Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative', Biology of Blood and Marrow Transplantation, vol. 19, no. 1, pp. 4-11. https://doi.org/10.1016/j.bbmt.2012.10.005

@article{60df1a12d0144933b88a68687ce9925b,

title = "Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative",

abstract = "The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. {"} Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative{"} used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.",

keywords = "Allogeneic transplant, Care delivery model, Healthcare disparities, Reimbursement, Workforce",

author = "Denzen, \{Ellen M.\} and Majhail, \{Navneet S.\} and \{Stickney Ferguson\}, Stacy and Claudio Anasetti and Arthur Bracey and Linda Burns and Richard Champlin and Jeffrey Chell and Helen Leather and Michael Lill and Maziarz, \{Richard T.\} and Erin Medoff and Joyce Neumann and Kim Schmit-Pokorny and Snyder, \{Edward L.\} and Laura Wiggins and \{Yolin Raley\}, \{Deborah S.\} and Murphy, \{Elizabeth A.\}",

note = "Funding Information: Financial disclosure: Funding for this conference was made possible (in part) by grant 1R13HL110705-01 from the National Institutes of Health, Yale School of Medicine, Yale University and the National Marrow Donor Program . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the US Government. The authors have no conflicts of interest to disclose. ",

year = "2013",

month = jan,

doi = "10.1016/j.bbmt.2012.10.005",

language = "English (US)",

volume = "19",

pages = "4--11",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier Inc.",

number = "1",

}

TY - JOUR

T1 - Hematopoietic Cell Transplantation in 2020

T2 - Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative

AU - Denzen, Ellen M.

AU - Majhail, Navneet S.

AU - Stickney Ferguson, Stacy

AU - Anasetti, Claudio

AU - Bracey, Arthur

AU - Burns, Linda

AU - Champlin, Richard

AU - Chell, Jeffrey

AU - Leather, Helen

AU - Lill, Michael

AU - Maziarz, Richard T.

AU - Medoff, Erin

AU - Neumann, Joyce

AU - Schmit-Pokorny, Kim

AU - Snyder, Edward L.

AU - Wiggins, Laura

AU - Yolin Raley, Deborah S.

AU - Murphy, Elizabeth A.

N1 - Funding Information: Financial disclosure: Funding for this conference was made possible (in part) by grant 1R13HL110705-01 from the National Institutes of Health, Yale School of Medicine, Yale University and the National Marrow Donor Program . The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the US Government. The authors have no conflicts of interest to disclose.

PY - 2013/1

Y1 - 2013/1

N2 - The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. " Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.

AB - The National Marrow Donor Program, in partnership with the American Society for Blood and Marrow Transplantation, sponsored and organized a series of symposia to identify complex issues affecting the delivery of hematopoietic cell transplantation (HCT) and to collaboratively develop options for solutions. " Hematopoietic Cell Transplantation in 2020: A System Capacity Initiative" used a deliberative process model to engage professional organizations, experts, transplant centers, and stakeholders in a national collaborative effort. Year 2 efforts emphasized data analysis and identification of innovative ideas to increase HCT system efficiency, address future capacity requirements, and ensure adequate reimbursement for HCT programs to meet the projected need for HCT. This report highlights the deliberations and recommendations of Year 2 and the associated symposium held in September 2011.

KW - Allogeneic transplant

KW - Care delivery model

KW - Healthcare disparities

KW - Reimbursement

KW - Workforce

UR - https://www.scopus.com/pages/publications/84871917059

UR - https://www.scopus.com/pages/publications/84871917059#tab=citedBy

U2 - 10.1016/j.bbmt.2012.10.005

DO - 10.1016/j.bbmt.2012.10.005

M3 - Article

C2 - 23078785

AN - SCOPUS:84871917059

SN - 1083-8791

VL - 19

SP - 4

EP - 11

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 1

ER -

Hematopoietic Cell Transplantation in 2020: Summary of Year 2 Recommendations of the National Marrow Donor Program's System Capacity Initiative

Abstract

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this